ZA882415B - Binder-free granules with delayed release of the active compound - Google Patents

Binder-free granules with delayed release of the active compound

Info

Publication number
ZA882415B
ZA882415B ZA882415A ZA882415A ZA882415B ZA 882415 B ZA882415 B ZA 882415B ZA 882415 A ZA882415 A ZA 882415A ZA 882415 A ZA882415 A ZA 882415A ZA 882415 B ZA882415 B ZA 882415B
Authority
ZA
South Africa
Prior art keywords
active compound
binder
delayed release
free granules
granulate
Prior art date
Application number
ZA882415A
Other languages
English (en)
Inventor
Korsatko Werner
Korsatko-Wabnegg Brigitta
Original Assignee
Chemie Holding Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Holding Aktiengesellschaft filed Critical Chemie Holding Aktiengesellschaft
Publication of ZA882415B publication Critical patent/ZA882415B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA882415A 1987-04-10 1988-04-07 Binder-free granules with delayed release of the active compound ZA882415B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873712095 DE3712095A1 (de) 1987-04-10 1987-04-10 Bindemittelfreies granulat mit verzoegerter wirkstoffabgabe

Publications (1)

Publication Number Publication Date
ZA882415B true ZA882415B (en) 1988-10-06

Family

ID=6325284

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882415A ZA882415B (en) 1987-04-10 1988-04-07 Binder-free granules with delayed release of the active compound

Country Status (10)

Country Link
US (1) US4902516A (es)
EP (1) EP0285871B1 (es)
JP (1) JPS63258810A (es)
AT (1) ATE77049T1 (es)
AU (1) AU600812B2 (es)
CA (1) CA1316826C (es)
DE (2) DE3712095A1 (es)
ES (1) ES2036609T3 (es)
GR (1) GR3004863T3 (es)
ZA (1) ZA882415B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334520A (en) * 1990-05-25 1994-08-02 Center For Innovative Technology Production of poly-beta-hydroxybutyrate in transformed escherichia coli
US5518907A (en) * 1989-06-07 1996-05-21 Center For Innovative Technology Cloning and expression in Escherichia coli of the Alcaligenes eutrophus H16 poly-beta-hydroxybutyrate biosynthetic pathway
EP0423484B1 (de) * 1989-10-16 1993-11-03 PCD-Polymere Gesellschaft m.b.H. Pressling mit retardierter Wirkstofffreisetzung
DE3935736A1 (de) * 1989-10-27 1991-05-02 Chemie Linz Deutschland Pressling mit retardierter wirkstofffreisetzung
DE59006217D1 (de) * 1989-11-30 1994-07-28 Danubia Petrochem Polymere Nicht wirkstoffretardierender Pressling, Verfahren zu dessen Herstellung und Verwendung von Polyhydroxybuttersäure zur Herstellung eines solchen Presslings.
DE4000155A1 (de) * 1990-01-04 1991-07-11 Chemie Linz Deutschland Nicht wirkstoffretardierender pressling, verfahren zu dessen herstellung und verwendung von polyhydroxybuttersaeure zur herstellung eines solchen presslings
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US6913768B2 (en) * 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
US20060275253A1 (en) 2003-09-01 2006-12-07 Kazunari Ushida Beta hydroxy short to medium chain fatty acid polymer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE6602562U (de) * 1967-07-28 1969-06-04 Calmic Eng Co Ltd Vorrichtung zum granulieren von feststoffen oder zum ueberziehen von feststoffteilchen
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
DE2620456A1 (de) * 1976-05-08 1977-11-10 Enterofagos Gmbh Galenische zubereitung in tablettenform
CH649217A5 (de) * 1977-08-25 1985-05-15 Sandoz Ag Bromocriptin enthaltende mikrokapseln.
US4166800A (en) * 1977-08-25 1979-09-04 Sandoz, Inc. Processes for preparation of microspheres
DE2917037C2 (de) * 1979-04-27 1980-12-11 Josef Dipl.-Chem. Dr. 8000 Muenchen Gaensheimer Parenteral arzneimittelhaltige partiell resorbierbare Mehrkomponentenmasse auf Basis von polymeren Stoffen
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
FR2492661A1 (fr) * 1980-10-28 1982-04-30 Laruelle Claude Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
AT382076B (de) * 1982-10-15 1987-01-12 Chemie Linz Ag Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
HUT35524A (en) * 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3343576A1 (de) * 1983-12-01 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur biotechnologischen herstellung von poly-d(-)-3-hydroxybuttersaeure
DE3571924D1 (en) * 1984-04-11 1989-09-07 Thiemann Arzneimittel Gmbh Dosage units for controlled release of active material
DE3417576A1 (de) * 1984-05-11 1985-11-14 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Retardformen des alpha-(2,5-dimethoxy-phenyl)-ss-glycinamidoaethanols und verfahren zu ihrer herstellung
DE3428372A1 (de) * 1984-08-01 1986-02-13 Hoechst Ag, 6230 Frankfurt Mikrokapseln von regulatorischen peptiden mit kontrollierter freisetzung, verfahren zu ihrer herstellung und injektionszubereitungen
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
DE3625548A1 (de) * 1986-07-29 1988-02-18 Bbc Brown Boveri & Cie Automatisch montierbarer elektrischer drucktastenschalter mit einem schwenkbar gelagerten druckbuegel

Also Published As

Publication number Publication date
GR3004863T3 (es) 1993-04-28
DE3712095A1 (de) 1988-10-20
EP0285871A2 (de) 1988-10-12
US4902516A (en) 1990-02-20
AU1435888A (en) 1988-10-13
JPS63258810A (ja) 1988-10-26
EP0285871A3 (en) 1989-12-13
ES2036609T3 (es) 1993-06-01
DE3871840D1 (de) 1992-07-16
EP0285871B1 (de) 1992-06-10
AU600812B2 (en) 1990-08-23
CA1316826C (en) 1993-04-27
ATE77049T1 (de) 1992-06-15

Similar Documents

Publication Publication Date Title
IL88736A (en) Coated microgranules as sustained release pharmaceuticals
CA2116120A1 (en) Peptides having growth hormone releasing activity
GR3025936T3 (en) Tablets, granulates and pellets with a high drug content for highly concentrated solid administration forms
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
JPS6426578A (en) 2,2-dimethylchroman-3-ol derivative, manufacture and drug composition
FI894899A0 (fi) Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi
NZ218734A (en) Tablets containing coated microspheres which contain ibuprofen (2-(4-isobutyl phenyl)propanoic acid)
ZA882415B (en) Binder-free granules with delayed release of the active compound
IT1219892B (it) Derivati dell' acido furanuronico,loro preparazione e loro impiego come medicamenti
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
HUT47794A (en) Insecticide, acaricide and nematocide compositions containing pyridazinone derivatives as active components and process for producing the active components
ZA837412B (en) Compressed products with retarded release of active substance
AU7095687A (en) Pellet-containing pharmaceutical compositions
FI900145A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
CA2079205A1 (en) Use of Hyaluronic Acid and Forms to Prevent Arterial Restenosis
EP0480391A3 (en) Emulsion-free emulsion polymers, their production and their use in sustained-release pharmaceutical compositions
EP0295783A3 (en) A derivative of codeine
JPS6470470A (en) Novel 1,2-diamino compound, manufacture and drug
NZ223138A (en) 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives and pharmaceutical compositions
ITMI913511A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8721454A0 (it) Composti ad attivita' antivirale, procedimento per la loro preparazione e relative composizioni farmaceutiche.
ITMI913512A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911444A0 (it) Derivati dell'eserolina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ZA883610B (en) A process for the preparation of 5-acylamino-2,4,6-triiodo-or tribromo-benzioc acid derivatives and the acid derivatives obtained by said process